Form 144 Phreesia For: 10 April
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Phreesia Inc (PHR)
Phreesia Inc stock price live, this page displays NYSE PHR stock exchange data. View the PHR premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Phreesia Inc real time stock price chart below.
What Is the Phreesia Inc Stock Price Today?
The Phreesia Inc stock price today is 8.06.
What Is the Stock Symbol for Phreesia Inc?
The stock symbol for Phreesia Inc is "PHR."
What Stock Exchange Does Phreesia Inc Trade On?
Phreesia Inc is listed and trades on the NYSE stock exchange.
Is Phreesia Inc a Good Stock to Buy?
Determining whether Phreesia Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the PHR quote. (ISIN: US71944F1066)
What Is the Phreesia Inc Stock Price Today?
The Phreesia Inc stock price today is 8.06.
What Is the Stock Symbol for Phreesia Inc?
The stock symbol for Phreesia Inc is "PHR."
What Stock Exchange Does Phreesia Inc Trade On?
Phreesia Inc is listed and trades on the NYSE stock exchange.
Is Phreesia Inc a Good Stock to Buy?
Determining whether Phreesia Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the PHR quote. (ISIN: US71944F1066)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
7.80
8.15
52 wk Range
7.77
32.76
PHR is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
7.808.15
52 wk Range
7.7732.76
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
PHR Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
16.44
Upside
+104.03%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
RSI suggests the stock is in oversold territory
- Form 13D/A Phreesia For: 2 April
- Investing.com
- Phreesia Inc receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Form 144 Phreesia For: 10 April
- Investing.com
- Phreesia Inc receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Top insider buys and sells disclosed on Thursday
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. It offers solutions including appointment optimization and referral management using AI-enabled workflows; and AI-based smart answering solution patient communications supported by voice and messaging solutions; integrated payment solutions embedded in intake and post-visit workflows, and financing solutions that enable healthcare organizations to accelerate cash collections while offering flexible payment options to patients; and digital intake and clinical data capture, patient engagement and activation tools, and measurement and analytics solutions. It also offers PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, which are on-site kiosks. The company serves a range of healthcare organizations including ambulatory practices, health systems, and hospitals, as well as life sciences companies, government entities, patient advocacy, public interest and not-for-profit and other organizations. Phreesia, Inc. was incorporated in 2005 and is based in Wilmington, Delaware.
Phreesia Inc SWOT Analysis
Digital Health Pionee | Explore Phreesia's multifaceted platform revolutionizing patient engagement, administrative efficiency, and pharmaceutical marketing in the evolving healthcare IT landscape |
Financial Momentum | Delve into Phreesia's impressive revenue growth, improving profitability metrics, and transition to positive adjusted EBITDA and free cash flow generation |
Strategic Expansion | Learn how Phreesia's partnerships with large specialty provider networks and diverse revenue streams are driving scalability and market penetration |
Market Outlook | Analyst price targets range from $34 to $35, reflecting confidence in Phreesia's growth potential and its positioning as a "growth-at-a-reasonable-price" opportunity |
Phreesia Inc Earnings Call Summary for Q4/2026
- Phreesia Q4 FY2026 EPS of $0.02 missed forecast by 66.67%; revenue of $127.1M slightly beat estimates, up 16% YoY; stock rose 3.92% to $11.11.
- Adjusted EBITDA reached $29.4M (23% margin); free cash flow hit record $28.5M, demonstrating strong operational efficiency despite earnings miss.
- FY2027 revenue guidance lowered 5-8% to $510-520M due to insurance changes, pharma spending uncertainty, and reduced vaccine market activity.
- AccessOne acquisition and ProviderConnect launch aim to expand market presence; AI integration expected to enhance patient and provider value proposition.
- Management maintains adjusted EBITDA guidance, signaling confidence in margin expansion; analysts project profitability this year amid industry headwinds.
Last Updated: 2026-03-30, 05:58 p/m
Read Full TranscriptCompare PHR to Peers and Sector
Metrics to compare | PHR | Sector Sector - Average of metrics from a broad group of related Technology sector companies | Relationship RelationshipPHRPeersSector | |
|---|---|---|---|---|
P/E Ratio | 212.4x | 16.1x | −0.4x | |
PEG Ratio | 2.05 | 0.05 | 0.00 | |
Price/Book | 1.5x | 1.7x | 2.6x | |
Price / LTM Sales | 1.0x | 1.1x | 3.2x | |
Upside (Analyst Target) | 92.3% | 65.8% | 51.4% | |
Fair Value Upside | Unlock | 45.8% | 6.7% | Unlock |
Analyst Ratings
15 Buy
5 Hold
0 Sell
Ratings:
20 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 16.44
(+104.03% Upside)
Earnings
Latest Release
Mar 30, 2026
EPS / Forecast
0.02 / 0.06
Revenue / Forecast
127.1M / 126.86M
People Also Watch
FAQ
What Is the Phreesia (PHR) Stock Price Today?
The Phreesia stock price today is 8.06 USD.
What Stock Exchange Does Phreesia Trade On?
Phreesia is listed and trades on the New York Stock Exchange.
What Is the Stock Symbol for Phreesia?
The stock symbol for Phreesia is "PHR."
What Is the Phreesia Market Cap?
As of today, Phreesia market cap is 489.75M USD.
What Is Phreesia's Earnings Per Share (TTM)?
The Phreesia EPS (TTM) is 0.04.
When Is the Next Phreesia Earnings Date?
Phreesia will release its next earnings report on May 28, 2026.
From a Technical Analysis Perspective, Is PHR a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Phreesia Stock Split?
Phreesia has split 0 times.
How Many Employees Does Phreesia Have?
Phreesia has 1789 employees.
What is the current trading status of Phreesia (PHR)?
As of Apr 12, 2026, Phreesia (PHR) is trading at a price of 8.06 USD, with a previous close of 8.09 USD. The stock has fluctuated within a day range of 7.80 USD to 8.15 USD, while its 52-week range spans from 7.77 USD to 32.76 USD.
What Is Phreesia (PHR) Price Target According to Analysts?
The average 12-month price target for Phreesia is 16.44 USD, with a high estimate of 24 USD and a low estimate of 10 USD. 15 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +104.03% Upside potential.
What Is the PHR Premarket Price?
PHR's last pre-market stock price is 8.24 USD. The pre-market share volume is 18,570.00, and the stock has decreased by 0.15, or 1.85%.
What Is the PHR After Hours Price?
PHR's last after hours stock price is 8.16 USD, the stock has decreased by 0.10, or 1.24%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.